New Zealand is leading the world in asthma management due to the nationwide uptake of a 2-in-1 inhaler regime.
Historically asthma has been treated by prescribing separate reliever and preventer inhalers, but the results of a recent study released by the Medical Research Institute of New Zealand show the combination 2-in-1 inhaler has significantly reduced the number of asthma related hospital admissions in Aotearoa over the last four years.
Professor Richard Beasley is the Director of the Medical Research Institute of New Zealand and is also the asthma programme lead.
Asthma 2-in-1 reliever. Photo: Asthma & Respiratory Foundation NZ
